Literature DB >> 27911584

Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.

Han Yue1, Jiang Qian1, Yifei Yuan1, Rui Zhang1, Yingwen Bi2, Fengxi Meng1, Yi Xuan1.   

Abstract

PURPOSE: To summarize the clinicopathological characteristics and prognosis of uveal melanoma (UM) after enucleation in Chinese patients.
METHODS: Between 2003 and 2012, a series of 171 patients with UM received enucleation at the Eye & ENT Hospital of Fudan University in Shanghai. Patient clinical information was collected. Pathological examination and BAP1 staining of the enucleated eyes were conducted. Univariate and multivariate Cox proportional hazard regressions were conducted to determine the risk factors, and the survival rates were calculated and compared.
RESULTS: The study included 83 (49%) men and 88 (51%) women, with a mean age of 48.6 years. The mean largest basal tumor diameter and mean largest tumor thickness were 11.8 and 8.6 mm, respectively. Ciliary body involvement was observed in 19 tumors (11%). Spindle and nonspindle patterns were observed in 100 (58%) and 71 eyes (42%), respectively. Extrascleral extension was observed in three eyes (2%). BAP1 staining was negative in 34% (53/156) of all tumors and 53% (19/36) of the cases with melanoma-related metastasis. The mean follow-up period was 63.4 months for all patients with the exception of 11 patients, who were excluded because they were lost during follow-up. A large basal tumor diameter, ciliary body involvement, nonspindle cell type, extrascleral extension, and negative BAP1 staining were associated with a worse prognosis. The survival curves significantly differed between the BAP1-negative and BAP1-positive groups (P = 0.004). According to Kaplan-Meier analysis, the 5- and 10-year metastasis-free survival rates were 80% and 70%, respectively.
CONCLUSIONS: A large basal tumor diameter, ciliary body involvement, nonspindle cell type, extrascleral extension, and negative BAP1 staining may be risk factors for the prediction of the UM prognosis. A younger age at diagnosis and a similar prognosis between genders may be unique features in Asian patients compared to the Caucasian population.

Entities:  

Keywords:  BAP1; cancer; pathology; prognosis; uveal melanoma

Mesh:

Substances:

Year:  2016        PMID: 27911584     DOI: 10.1080/02713683.2016.1245422

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  12 in total

1.  Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.

Authors:  Eszter Szalai; Jill R Wells; Laura Ward; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2017-08-18       Impact factor: 12.079

2.  Calpastatin participates in the regulation of cell migration in BAP1-deficient uveal melanoma cells.

Authors:  Han Yue; Feng-Xi Meng; Jiang Qian; Bin-Bin Xu; Gang Li; Ji-Hong Wu
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

3.  Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea.

Authors:  Su-Kyung Jung; Young-Hoon Park; Dong-Ho Shin; Hak-Soo Kim; Jong-Hwi Jung; Tae-Hyun Kim; Sung Ho Moon
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

Review 4.  Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.

Authors:  Natasha M van Poppelen; Daniël P de Bruyn; Tolga Bicer; Rob Verdijk; Nicole Naus; Hanneke Mensink; Dion Paridaens; Annelies de Klein; Erwin Brosens; Emine Kiliҫ
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

5.  Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.

Authors:  Qiaozhu Zeng; Yuou Yao; Mingwei Zhao
Journal:  BMC Ophthalmol       Date:  2021-05-25       Impact factor: 2.209

6.  A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.

Authors:  Jun Liu; Jianjun Lu; Wenli Li
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

7.  The Clinical Feature and Treatment Outcome of Ocular Melanoma: A 34-Year Experience in a Tertiary Referral Center.

Authors:  Yu-Yun Huang; Tzu-Yu Hou; Wei-Kuang Yu; Chieh-Chih Tsai; Shu-Ching Kao; Wen-Ming Hsu; Jui-Ling Catherine Liu
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

Review 8.  Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis.

Authors:  Carla Enrica Gallenga; Elena Franco; Ginevra Giovanna Adamo; Sara Silvia Violanti; Paolo Tassinari; Mauro Tognon; Paolo Perri
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

Review 9.  Uveal Melanoma in Asians: A Review.

Authors:  Pradeep Manchegowda; Arun D Singh; Carol Shields; Swathi Kaliki; Parag Shah; Lingam Gopal; Pukhraj Rishi
Journal:  Ocul Oncol Pathol       Date:  2021-02-09

10.  Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort.

Authors:  Laura Ling Ying Tan; Jiancheng Hong; Wei Lin Goh; Esther Wei Yin Chang; Valerie Shiwen Yang; Eileen Poon; Nagavalli Somasundaram; Mohamad Farid; Anita Sook Yee Chan; Jason Yongsheng Chan
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.